You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment Naïve, Chronic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN

Terminated
  • HBe Negative Chronic Hepatitis B
  • Hepatitis B Viral Infection
  • CLEVUDINE + TENOFOVIR PLACEBO
  • +2 more
  • Marseille, France
    Hôpital Saint Joseph
Jan 30, 2023

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

Completed
  • Chronic Hepatitis B
  • NCO-48 Fumarate 4 mg
  • +2 more
  • Monterey Park, California
    National Institute of Clinical Research, Inc
Jan 3, 2023

Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)

Recruiting
  • Chronic Hepatitis b
  • Placebo
  • +4 more
  • Chongqing, Chongqing, China
  • +2 more
Nov 27, 2023

Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

Suspended
  • Anemia of Chronic Kidney Disease
  • Hackensack, New Jersey
    Research Site
Aug 23, 2022

Opioid-use Disorder, Opioid Use, Opioid Abuse Trial in Minneapolis (Choice Architecture Nudge, PMP Integration & Nudge)

Recruiting
  • Opioid-use Disorder
  • +2 more
  • Choice Architecture Nudge
  • PMP Integration & Nudge
  • Minneapolis, Minnesota
    University of Minnesota
Aug 3, 2022

Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

Completed
Has Results
  • Hepatitis
  • Safety and Tolerability
  • HEPLISAV-B
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2022

Chronic Pulmonary Aspergillosis Trial in Chandigarh (Itraconazole 200 mg, Voriconazole 200mg)

Recruiting
  • Chronic Pulmonary Aspergillosis
  • Itraconazole 200 mg
  • Voriconazole 200mg
  • Chandigarh, India
  • +1 more
Jun 10, 2022

Chronic Lymphocytic Leukemia (CLL) Trial (Venetoclax, Rituximab, Ibrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Apr 2, 2022

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • Lauderdale Lakes, Florida
    South Florida Research Institute
Sep 28, 2022

US Based on Pharmacy and Medical Claims That Compares How Well

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • White Plains, New York
    eMax health
Jan 11, 2022

Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
  • Mansoura, Egypt
    Mansoura University Children Hospital
Oct 21, 2021

Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib and obinutuzumab
  • Milano, MI, Italy
    Strategic Research Program on CLL
Apr 2, 2022

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Fort Myers, Saint Petersburg, Nashville (Ublituximab, Umbralisib)

Terminated
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
Jul 20, 2022

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for

Recruiting
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 7, 2023

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine and Cedazuridine, Venetoclax)

    Recruiting
    • Chronic Myelomonocytic Leukemia
    • Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

    Active, not recruiting
    • Relapsed/Refractory B Cell Malignancies
    • +3 more
    • Columbus, Ohio
    • +17 more
    Aug 18, 2022

    Opioid Induced Respiratory Depression, Chronic Opioid Use Trial in Leiden (Narcan 40 MG/ML Nasal Spray, Naloxone Hydrochloride)

    Recruiting
    • Opioid Induced Respiratory Depression
    • Chronic Opioid Use
    • Narcan 40 MG/ML Nasal Spray
    • Naloxone Hydrochloride
    • Leiden, ZH, Netherlands
      Leiden University Medical Center
    Jan 12, 2023

    Chronic Pulmonary Aspergillosis Trial in Chandigarh (Itraconazole 400 mg)

    Completed
    • Chronic Pulmonary Aspergillosis
    • Itraconazole 400 mg
    • Chandigarh, India
      Inderpaul Singh
    Oct 11, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022